Paul Coletta

Vero measures and optimizes organ health using advanced proteomics and AI to detect aging and disease risk at the organ level. Unlike diagnostics that focus on biological age or disease detection, Vero identifies early dysfunction before disease manifests, delivering actionable, organ-specific insights. It then recommends targeted interventions ranging from lifestyle changes to third-party FDA-regulated treatments and validates their effectiveness through a test-retest model. This continuous feedback loop empowers individuals to proactively manage their health, extend their healthspan, and delay disease onset.